- Previous Close
14.57 - Open
14.10 - Bid 13.87 x --
- Ask 13.88 x --
- Day's Range
13.68 - 14.10 - 52 Week Range
11.77 - 21.58 - Volume
20,654,655 - Avg. Volume
8,711,968 - Market Cap (intraday)
7.898B - Beta (5Y Monthly) --
- PE Ratio (TTM)
20.40 - EPS (TTM)
0.68 - Earnings Date --
- Forward Dividend & Yield 0.37 (2.68%)
- Ex-Dividend Date May 31, 2024
- 1y Target Est
--
Jiangsu Kanion Pharmaceutical Co.,Ltd. researches and develops, produces, and sells Chinese medicines. It also offers medicines in the fields of anti-infections, orthopedics, gynecology, cardio and cerebrovascular, tonic-class, and others. In addition, the company provides herb extracts and formula granules, as well as OEM/ODM services. Jiangsu Kanion Pharmaceutical Co.,Ltd. was founded in 1975 and is based in Lianyungang, China.
www.kanion.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 600557.SS
View MorePerformance Overview: 600557.SS
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 600557.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 600557.SS
View MoreValuation Measures
Market Cap
8.30B
Enterprise Value
6.06B
Trailing P/E
20.40
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.05
Price/Book (mrq)
1.75
Enterprise Value/Revenue
1.45
Enterprise Value/EBITDA
9.33
Financial Highlights
Profitability and Income Statement
Profit Margin
10.05%
Return on Assets (ttm)
3.44%
Return on Equity (ttm)
7.55%
Revenue (ttm)
3.9B
Net Income Avi to Common (ttm)
391.86M
Diluted EPS (ttm)
0.68
Balance Sheet and Cash Flow
Total Cash (mrq)
2.24B
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
664.74M